The double upgrade from a firm with a perfect track record on SOLS is a powerful bullish signal despite the lower PT. Traders should view this as a catalyst for near-term momentum, particularly given the positive EPS revision trend and supportive consensus.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 13 $61.06entry
- T+1 · 4mo ago +3.77%α +3.41% · $63.36
- T+5 · 4mo ago −4.39%α −3.60% · $58.38
- T+20 · 3mo ago −1.21%α −4.40% · $60.32
- T+60 · 6w ago +0.34%α −3.65% · $61.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
UBS double-upgraded Solstice Advanced Materials (SOLS) from Neutral to Buy on July 13, while cutting its price target from $88 to $78. The new target implies 27% upside from the current $61.30 close. UBS holds a perfect 100% accuracy rate on its two prior SOLS calls and ranks as a top-tier performer on the name. The consensus is bullish, 8 Buy ratings (62%) vs 5 Holds (38%), with a mean target of $89.43 and a high of $102. Momentum is supportive: two upgrades in the past 30 days with no downgrades, and EPS estimates for the current fiscal year have edged up 0.7% over the past month. Institutional activity is mixed, Walleye Capital more than doubled its position while Schonfeld exited, but the double upgrade from a high-accuracy firm provides a clear vote of confidence. Bottom line: despite the PT reduction, this upgrade signals a fundamental inflection and warrants attention from momentum traders.
Impact Score
Consensus & Targets
Of 13 analysts covering SOLS, 62% rate it a Buy (2 Strong Buy, 6 Buy) and 38% rate it Hold (5 Hold). No Sell ratings exist. The consensus is firmly bullish, and UBS’s upgrade aligns with the majority view.
The mean price target is $89.43, median $90, high $102, and low $75. Current price of $61.30 implies 45.9% upside to the mean. UBS’s $78 target sits below both the mean and median, reflecting a more conservative valuation versus the Street, but still well above the current price.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-13 | UBS | upgrade | Buy | $78.00 |
| 2026-07-09 | Truist Securities | upgrade | Buy | No target |
| 2026-07-01 | Mizuho | maintain | Neutral | $95.00 |
| 2026-06-30 | RBC Capital | maintain | Outperform | $102.00 |
| 2026-06-08 | Truist Securities | initiate | Hold | $90.00 |
| 2026-06-05 | RBC Capital | maintain | Outperform | $100.00 |
| 2026-06-05 | BMO Capital | maintain | Outperform | $101.00 |
| 2026-05-08 | UBS | maintain | Neutral | $88.00 |
| 2026-04-14 | UBS | downgrade | Neutral | $87.00 |
| 2026-02-12 | BMO Capital | maintain | Outperform | $90.00 |
Analyst activity is positive: 2 upgrades in the past 30 days (UBS and Truist Securities) and 0 downgrades. EPS revisions show a slight upward bias, the current fiscal-year EPS estimate has risen from $2.629 to $2.646 over 30 days, with 2 upward revisions versus 3 downward (the net is modestly positive due to larger magnitude of upgrades).
Firm Track Record: UBS
UBS accuracy: 55% on 5074 calls | avg return: 4.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 1 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| UBS | 100% | 2/2 | 60.5% | top tier |
UBS has a 100% accuracy rate on SOLS (2 correct out of 2 calls), with an average return of 60.5% on those ratings, placing it in the top tier among covering firms. This outperformance lends extra weight to the upgrade, even with the concurrent PT cut.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $2.65 | $2.56 to $2.70 | $4.1B | ↑2 ↓0 |
| +1y | $3.21 | $3.13 to $3.32 | $4.3B | ↑2 ↓0 |
| 0q | $0.78 | $0.76 to $0.79 | $1.1B | ↑2 ↓0 |
| +1q | $0.67 | $0.64 to $0.70 | $1.0B | ↑1 ↓0 |
Cross-Platform Signals
No insider trades or congressional trades are recorded. Institutional activity is mixed: Walleye Capital increased its position by 240% (now $9.1M), while Schonfeld trimmed by 83% and Jefferies reduced by 58%. The large institutional buy from Walleye converges with the bullish analyst signal, but the trims introduce some uncertainty. Short interest data is unavailable.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
26 reports on SOLS
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +16.38% at T+5 after the Nov 4, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $65.02 Now $64.92 −0.15% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $57.70 to $67.15 Now $64.92 +12.51% ▲ +16.38% +17.29% vs SPY
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $57.70 to $67.15 Now $64.92 +12.51% ▲ +16.38% +17.29% vs SPY
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $57.70 to $67.15 Now $64.92 +12.51% ▲ +16.38% +17.29% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $60.55 to $58.00 Now $64.92 +7.22% ▼ −4.21% −1.51% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.25 to $57.70 Now $64.92 +2.64% ▼ −8.77% −8.06% vs SPY
- Oct 13, 20264w ago ANALYST-UPGRADE Bullish 4/10 Entry $60.91 to $62.71 Now $64.92 +6.58% ▲ +2.96% +3.95% vs SPY
- Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $60.36 to $60.13 Now $64.92 +7.55% ▼ −0.38% +0.60% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $56.98 to $60.23 Now $64.92 +13.93% ▲ +5.70% +4.40% vs SPY
- Aug 27, 202611w ago Press Release Bullish 6/10 Entry $63.53 to $63.73 Now $64.92 +2.19% ▲ +0.31% +0.21% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers